Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
6.50
+0.12 (1.88%)
At close: Nov 3, 2026, 4:00 PM EST
6.78
+0.28 (4.31%)
Pre-market: Nov 4, 2026, 5:12 AM EST
Alumis Employees
As of June 30, 2026, Alumis had 239 total employees, including 237 full-time and 2 part-time employees. The number of employees increased by 12 or 5.29% compared to the same quarter last year. That makes Alumis the 25,497th largest employer in the world and 3,268th in the United States.
Employees
239
Change (1Y)
12
Growth (1Y)
5.29%
Revenue / Employee
$30,954
Profits / Employee
-$1,836,640
Market Cap
841.33M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 239 | 12 | 5.29% | 237 | 2 |
| Mar 31, 2026 | 227 | 43 | 23.37% | 225 | 2 |
| Dec 31, 2025 | 224 | 54 | 31.76% | 221 | 3 |
| Sep 30, 2025 | 223 | 76 | 51.70% | 221 | 2 |
| Jun 30, 2025 | 227 | 97 | 74.62% | 225 | 2 |
| Mar 31, 2025 | 184 | 75 | 68.81% | 182 | 2 |
| Dec 31, 2024 | 170 | 61 | 55.96% | 168 | 2 |
| Sep 30, 2024 | 147 | 38 | 34.86% | 145 | 2 |
| Jun 30, 2024 | 130 | - | - | 128 | 2 |
| Mar 31, 2024 | 109 | - | - | 107 | 2 |
| Dec 31, 2023 | 109 | - | - | 107 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| MeiraGTx Holdings | 393 |
| Kura Oncology | 260 |
| Prime Medicine | 146 |
| Inventiva | 87 |
| Alto Neuroscience | 68 |
| Jade Biosciences | 55 |
| Corvus Pharmaceuticals | 37 |
ALMS News
- 26 days ago - Alumis announces new envudeucitinib data from ONWARD clinical program - TheFly
- 26 days ago - Alumis Announces New Phase 3 Data Demonstrating Envudeucitinib Rapidly and Durably Improved Psoriasis Burden Across Scalp, Itch, and Quality of Life Measures - GlobeNewsWire
- 7 weeks ago - Alumis Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - Alumis Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 1 month ago - Alumis Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 2 months ago - Alumis to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 2 months ago - Alumis downgraded to Neutral from Buy at Guggenheim - TheFly
- 2 months ago - Alumis rises 10.7% - TheFly